SRT1720 is primarily researched for its potential therapeutic applications, particularly in the field of aging and metabolic disorders. It is known to activate sirtuin 1 (SIRT1), a protein associated with longevity and cellular health. Studies suggest it may improve insulin sensitivity and glucose metabolism, making it a candidate for managing type 2 diabetes. Additionally, SRT1720 has shown promise in enhancing mitochondrial function and reducing oxidative stress, which could benefit neurodegenerative diseases like Alzheimer's. Research also explores its role in combating obesity by promoting fat metabolism and reducing inflammation. Preliminary studies indicate potential anti-cancer effects by inhibiting the growth of cancer cells. However, its clinical efficacy and safety are still under investigation, and it is not yet approved for medical use.